VAYA Pharma Introduces New Three-Month Supply of Vayarin® and Vayacog® Medical Foods
May 02 2017 - 8:30AM
VAYA Pharma, a division of Enzymotec Ltd (NASDAQ:ENZY) and
innovator of lipid-based medical foods, today announced the
availability of new three-month bottles of its prescription medical
foods Vayarin® and Vayacog®. The new product offerings, which are
based on the recommended daily dosage found on the labels, will
give patients the convenience and cost savings of multiple-month
refills of Vayarin and Vayacog, which help manage the nutritional
deficiencies associated with attention deficient hyperactivity
disorder (ADHD) and early memory impairment (EMI), respectively.
Three-month bottles of Vayarin and Vayacog are available
exclusively through VAYA Direct – VAYA Pharma’s online fulfillment
center – for $148.50.
“We are excited to expand our product portfolio and deliver a
three-month supply of Vayarin and Vayacog in convenient packaging
to help streamline refills for patients,” commented Rob Crim, CEO
of VAYA Pharma. “Our hope is that the new three-month bottles will
encourage patients to adhere to their care plan as Vayarin and
Vayacog will be easier to refill and patients will experience a
cost savings with the new, larger bottles.”
VAYA Pharma offers one-month bottles of Vayarin and Vayacog for
$54.50 through VAYA Direct. To learn more or to change a future
refill, please email VAYA Direct at order@vaya-direct.com or call
toll free at 844-4-VDIRECT (844-483-4732).
To learn more about Vayarin and Vayacog, please visit
www.vayarin.com and www.vayacog.com.
Vayarin® and Vayacog®Vayarin and Vayacog are
FDA-regulated prescription medical foods, clinically shown to
safely and effectively manage nutritional deficiencies associated
with ADHD and EMI, respectively. Vayarin helps to reduce ADHD
behaviors and improve the quality of life in children. Vayacog
helps to improve memory and cognitive abilities in adults with EMI.
Vayarin and Vayacog, available in capsule form, are made of
Generally Recognized as Safe (GRAS) ingredients.
VAYA PharmaVAYA Pharma, a division of Enzymotec
Ltd (NASDAQ:ENZY), is the innovator of lipid-based medical foods
that are used to manage distinct nutritional deficiencies
associated with certain diseases and health conditions, including
attention deficit hyperactivity disorder (ADHD), early memory
impairment (EMI) and hypertriglyceridemia. Committed to safety and
efficacy, VAYA Pharma’s innovations – Vayarin®, Vayacog® and
Vayarol® – are backed by years of clinical research. Its products
are available in the U.S. by prescription for use under the
supervision of a physician. VAYA Pharma is headquartered in
Baltimore, Maryland. For more information, visit
www.vayapharma.com. Forward-Looking StatementsThis
press release may contain forward-looking statements related to
VAYA Pharma’s business strategy, outlook, objectives, plans,
intentions or goals. The words "may," "will," "should," "plans,"
"explores," "expects," "anticipates," "continue," "estimate,"
"project," "intend," and similar expressions, identify
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, but their absence does
not mean that the statement is not forward-looking. These
statements are not guarantees of future performance and are subject
to certain risks, uncertainties, and assumptions that are difficult
to predict. Actual results could differ materially. VAYA Pharma
expressly disclaims any obligation or undertaking to update or
revise any forward-looking statement contained herein to reflect
any change in the company's expectations with regard thereto or any
change in events, conditions or circumstances upon which any
statement is based.
For more information:
VAYA Pharma
Shervin Esfahani
443.995.4299
ShervinE@vayapharma.com
Andrea Martin (on behalf of VAYA Pharma)
Andrea D. Martin Consulting, LLC
443.927.6183
andrea@consultmartin.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Aug 2024 to Sep 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Sep 2023 to Sep 2024